Notably, formononetin also acts as a phytoestrogen and has been shown to act on the estrogen receptor-beta (ERβ) with anti-tumor effects on ER positive breast cancer cells (Chen et al., 2013). This evidence concerns the gene ESR2 and breast carcinoma.